AU Patent

AU2020376792B2 — Heterocyclic carboxylate compounds as glycolate oxidase inhibitors

Assigned to Lilac Therapeutics Inc · Expires 2025-10-02 · 1y expired

What this patent protects

The present disclosure relates generally to modulators of human glycolate oxidase enzyme and methods of use and manufacture thereof. (I)

USPTO Abstract

The present disclosure relates generally to modulators of human glycolate oxidase enzyme and methods of use and manufacture thereof. (I)

Drugs covered by this patent

Patent Metadata

Patent number
AU2020376792B2
Jurisdiction
AU
Classification
—
Expires
2025-10-02
Drug substance claim
No
Drug product claim
No
Assignee
Lilac Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.